Aratana Therapeutics, Inc. Revenue per Employee (PETX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aratana Therapeutics, Inc.  (PETX)
 

Aratana Therapeutics's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 82.04% in the first quarter 2019, year on year to cumulative value of $39 million, Aratana Therapeutics's revenue per employee grew on a trailing twelve months basis to $ 634,902. The productivity of Aratana Therapeutics's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 42 other companies have achieved higher revenue per employee. While Aratana Therapeutics's total ranking has deteriorated compared to the previous quarter from 0 to 919. Aratana Therapeutics has 61 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PETX Revenue per Employee (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Revenue Change 82.04 % -53.08 % 249.75 % -4.85 % 6.53 %
Sales per Employee (TTM) $ 634,902 580,525 671,525 419,197 423,295
PETX's Total Ranking # 919 # 0 # 0 # 0 # 0
Seq. Revenue Change 50.02 % -77.24 % 339.18 % 21.4 % -61.34 %

PETX Company Profile >> Back to PETX Efficiency Comparisons >> Compare PETX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 43
Overall Market # 919

Revenue per Employee Statistics
High Average Low
$ 771,148 $ 439,563 $ 11,115
(Jun 30 2017)   (Dec. 30, 2015)



Financial Statements
Aratana Therapeutics's Revenue MRQ $ 7 Millions Visit PETX's Income Statement
Aratana Therapeutics's Revenues TTM $ 39 Millions Visit PETX's aggregate revenue growth
What are PETX's Sales? Visit PETX's Sales by Segment




Other Ratios
Aratana Therapeutics's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PETX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PETX's Competitors
Revenue per Employee for PETX's Suppliers
Revenue per Employee for PETX's Customers

You may also want to know
PETX's Sales Growth Rates PETX's Pe Price to earnings ratio PETX's Receivables Turnover Ratio PETX's Stock Quote
PETX's Net Income Growth Rates PETX's Ps Price to Sales ratio PETX's Sales per Employee PETX's Asset Turnover Ratio
PETX's Net Margin PETX's Pb Price to Book ratio PETX's Financial Strength Ratios PETX's Dividend Payout Ratio
Date modified: 2026-08-29T17:20:13+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2019, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2019Number of Employees Mar 31 2019
Cytomx Therapeutics Inc   1,084,101.45 $ 74.803  Million 69 
Yunhong Green Cti Ltd   1,041,313.73 $ 54.148  Million 52 
Endo International Plc  1,012,269.53 $ 2,966.962  Million 2,931 
Novelion Therapeutics Inc   1,008,567.16 $ 135.148  Million 134 
Lifevantage Corp  1,003,681.61 $ 223.821  Million 223 
Surgalign Holdings Inc   989,365.08 $ 186.990  Million 189 
Qc Technologies Inc   987,609.00 $ 1.975  Million 2 
Integrated Biopharma Inc  979,160.00 $ 48.958  Million 50 
Horizon Therapeutics Public Limited Company  972,353.85 $ 1,264.060  Million 1,300 
Emergent Biosolutions Inc   950,206.67 $ 855.186  Million 900 
Xoma Royalty Corporation  926,214.29 $ 12.967  Million 14 
Heron Therapeutics Inc   829,796.88 $ 106.214  Million 128 
Pediatrix Medical Group Inc   825,174.52 $ 5,409.019  Million 6,555 
Prophase Labs Inc   801,210.53 $ 15.223  Million 19 
Forte Biosciences Inc   784,565.22 $ 18.045  Million 23 
Carlisle Companies Incorporated  774,016.95 $ 4,566.700  Million 5,900 
Abiomed Inc   769,432.00 $ 769.432  Million 1,000 
Semler Scientific inc   767,387.10 $ 23.789  Million 31 
Journey Medical Corp  767,103.45 $ 44.492  Million 58 
Exelixis Inc   747,137.75 $ 856.967  Million 1,147 
Patterson Companies Inc   733,489.87 $ 5,574.523  Million 7,600 
Dynatronics Corporation  726,805.23 $ 63.959  Million 88 
Aptevo Therapeutics Inc   722,722.22 $ 26.018  Million 36 
Pfizer Inc  718,120.00 $ 53,859.000  Million 75,000 
Bristol myers Squibb Company  716,553.85 $ 23,288.000  Million 32,500 
Sorrento Therapeutics Inc   703,000.00 $ 21.090  Million 30 
Incyte Corporation  702,341.07 $ 1,997.458  Million 2,844 
Collegium Pharmaceutical Inc   688,368.79 $ 291.180  Million 423 
Jazz Pharmaceuticals Plc  676,295.85 $ 1,954.495  Million 2,890 
Milestone Scientific Inc   648,825.33 $ 9.732  Million 15 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.